Bayer establishes new cell and gene therapy platform
Bayer has launched a Cell and Gene Therapy (C>) Platform, aiming to accelerate its presence in this area.
We use necessary cookies to make our site work. We'd also like to set analytical cookies to help us improve our service, but we'd like your permission first. Please choose which cookies you're happy for us to set.